A clinical presentation of herpangina with ulcerative lesion over uvula

Pawan Banduji Itankar, Gaurav Rajendra Sawarkar

PAMJ. 2024; 48:133. Published 24 Jul 2024 | doi:10.11604/pamj.2024.48.133.43209

A 23-year-old male patient came´s to the outpatient department (OPD) with complaints of an ulcerative lesion over the uvula, fever, headache, and throat pain for 3 to 4 days, and no past medical history. He took antibiotics (azithromycin) and nonsteroidal anti-inflammatory drugs (NSAIDs) (paracetamol+ibuprofen) for three days after taking NSAIDs only the pain subsided but didn´t get relief from the ulcerative lesion. Therefore, an antiviral (Acicylovir) prescribed for five days helps to relieve associated symptoms, and the ulcerative lesion healed completely. Enteroviruses (i.e group A coxsackie virus) are the source of the viral infection known as herpangina, which often strikes children under the age of ten years; though it can strike anybody at any age depending on the immunity of an individual and is seen during autumn and summer season for 7 to 10 days. Clinically, it is an acute self-limiting tiny ulcerative or vesicular lesion in the posterior oropharynx, uvula, and throat region accompanied by an intense fever associated with headache and loss of appetite. Uses of antibiotics are ineffective in such conditions.
Corresponding author
Pawan Banduji Itankar, Department of Rachana Sharir, Mahatma Gandhi Ayurved College Hospital and Research Centre, Datta Meghe Institute of Higher Education and Research (Deemed to be University) Salod (H), Wardha, India (pawan.bitankar@gmail.com)

This image

  • HTML
  • PDF in process
Articles published in PAMJ are Open Access and distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0).

eISSN: 1937-8688


The Pan African Medical Journal (ISSN: 1937-8688) is a subsidiary of the Pan African Medical Journal. The contents of this journal is intended exclusively for professionals in the medical, paramedical and public health and other health sectors.

Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, ESCI

Physical address: "Kenya: 3rd Floor, Park Suite Building, Parkland Road, Nairobi. PoBox 38583-00100, tel: +254 (0)20-520-4356 | Cameroon: Immeuble TechnoPark Essos, Yaounde, PoBox: 10020 Yaounde, tel: +237 (0)24-309-5880"